$5.73
N/A
Last update: Nov 10, 4:27 PM
Orchestra BioMed Holdings Inc
OBIONASDAQ
The average analyst price target for Orchestra BioMed Hldgs is $12.56, 119.2% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $10 to $20. The latest change came on Sep 15, 2026, when B. Riley Securities raised its price target on Orchestra BioMed Hldgs from $10 to $11 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
